Journal
Oncology and Therapy
Publication Date
6-1-2022
Volume
10
Issue
1
First Page
279
Last Page
289
Document Type
Open Access Publication
DOI
10.1007/s40487-021-00178-w
Rights and Permissions
Kruse, M.L., Kang, I.M., Bagegni, N.A. et al. Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature. Oncol Ther 10, 279–289 (2022). https://doi.org/10.1007/s40487-021-00178-w This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Kruse, Megan L; Kang, Irene M; Bagegni, Nusayba A; Howell, W Todd; Moore, Halle C F; Bedell, Cynthia H; and Stokoe, Christopher T, "Management of diarrhea in patients with HER2-positive breast cancer treated with neratinib: A case series and summary of the literature." Oncology and Therapy. 10, 1. 279 - 289. (2022).
https://digitalcommons.wustl.edu/oa_4/3299
Department
ICTS (Institute of Clinical and Translational Sciences)
